Page last updated: 2024-10-16

carnitine and Cavernitis, Fibrous

carnitine has been researched along with Cavernitis, Fibrous in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jordan, GH1
Carson, CC1
Lipshultz, LI1
Larsen, SM1
Levine, LA2
Cavallini, G2
Safarinejad, MR1
Hosseini, SY1
Kolahi, AA1
Taylor, FL1
Biagiotti, G1
Koverech, A1
Vitali, G1

Reviews

4 reviews available for carnitine and Cavernitis, Fibrous

ArticleYear
Minimally invasive treatment of Peyronie's disease: evidence-based progress.
    BJU international, 2014, Volume: 114, Issue:1

    Topics: 4-Aminobenzoic Acid; Administration, Oral; Calcium Channel Blockers; Carnitine; Colchicine; Evidence

2014
Peyronie's disease: review of nonsurgical treatment options.
    The Urologic clinics of North America, 2011, Volume: 38, Issue:2

    Topics: 4-Aminobenzoic Acid; Calcium Channel Blockers; Carnitine; Colchicine; Collagenases; Combined Modalit

2011
Towards an evidence-based understanding of Peyronie's disease.
    International journal of STD & AIDS, 2005, Volume: 16, Issue:3

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Carnitine; Evidence-Based Medicine; Fibroblasts; Huma

2005
Non-surgical therapy of Peyronie's disease.
    Asian journal of andrology, 2008, Volume: 10, Issue:1

    Topics: Animals; Arginine; Carnitine; Collagenases; Combined Modality Therapy; Electric Stimulation Therapy;

2008

Trials

2 trials available for carnitine and Cavernitis, Fibrous

ArticleYear
Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study.
    The Journal of urology, 2007, Volume: 178, Issue:4 Pt 1

    Topics: Administration, Oral; Adult; Carnitine; Double-Blind Method; Drug Therapy, Combination; Follow-Up St

2007
Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease.
    BJU international, 2002, Volume: 89, Issue:9

    Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Ca

2002